13/12/2013
Cough And Cold Medicines Recalled
Thousands of bottles of Tixylix cough and cold medicines, manufactured by drug company Novartis, are being recalled over fears that plastic may have gotten into the medicines.
It is understood that Novartis has been made aware of a possible fault in the tamper seal of the bottles.
The medicines being recalled are:
Tixylix Toddler Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Toddler Syrup 150ml - PL 00030/0150 (Glycerol)
Tixylix Baby Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Blackcurrant Flavour Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Chesty Cough 100ml - PL 00030/0082 (Guaifenesin)
All were manufactured from October 2012 onwards.
There is no evidence that anyone has been harmed, but Novartis has set up a helpline on 0800 854 100.
The medicines should be returned to the point of purchase.
(MH)
It is understood that Novartis has been made aware of a possible fault in the tamper seal of the bottles.
The medicines being recalled are:
Tixylix Toddler Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Toddler Syrup 150ml - PL 00030/0150 (Glycerol)
Tixylix Baby Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Blackcurrant Flavour Syrup 100ml - PL 00030/0150 (Glycerol)
Tixylix Chesty Cough 100ml - PL 00030/0082 (Guaifenesin)
All were manufactured from October 2012 onwards.
There is no evidence that anyone has been harmed, but Novartis has set up a helpline on 0800 854 100.
The medicines should be returned to the point of purchase.
(MH)
Related UK National News Stories
Click here for the latest headlines.
24 May 2006
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
17 August 2004
New plans to focus on providing better medicines for children
A new initiative to encourage the development of more medicines designed specifically for use in children has been announced today by the government. The new paediatric medicines strategy is aimed at encouraging manufacturers of medicines to research and develop medicines geared to the needs of children.
New plans to focus on providing better medicines for children
A new initiative to encourage the development of more medicines designed specifically for use in children has been announced today by the government. The new paediatric medicines strategy is aimed at encouraging manufacturers of medicines to research and develop medicines geared to the needs of children.
13 October 2010
Patients And Doctors Misled By Data On Medicines
According to a comprehensive study of the evidence published on bmj.com today, the drug reboxetine is, overall, an ineffective and potentially harmful antidepressant.
Patients And Doctors Misled By Data On Medicines
According to a comprehensive study of the evidence published on bmj.com today, the drug reboxetine is, overall, an ineffective and potentially harmful antidepressant.
06 August 2009
Alternative Medicines Face Regulation
A consultation on whether, and if so, how practitioners of acupuncture, herbal medicine and traditional Chinese medicine should be regulated was launched this week by the Department of Health. At present, there is no statutory regulation of practitioners who offer acupuncture, herbal medicine and traditional Chinese medicine in the UK.
Alternative Medicines Face Regulation
A consultation on whether, and if so, how practitioners of acupuncture, herbal medicine and traditional Chinese medicine should be regulated was launched this week by the Department of Health. At present, there is no statutory regulation of practitioners who offer acupuncture, herbal medicine and traditional Chinese medicine in the UK.
27 March 2008
Infant Cough Medicines Pulled From Shelves
A number of cough and cold remedies aimed at very young children are being removed from shop shelves due to concerns over accidental overdoses.
Infant Cough Medicines Pulled From Shelves
A number of cough and cold remedies aimed at very young children are being removed from shop shelves due to concerns over accidental overdoses.